Fortis Malar Hospitals Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 30, 2026

Key Highlights

The Latest Trading Price of Fortis Malar Hospitals Ltd is ₹ 39.47 as of 30 Oct 15:30 . The P/E Ratio of Fortis Malar Hospitals Ltd changed from 1.9 on March 2024 to 18.9 on March 2026 . This represents a CAGR of 115.06% over 3 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 42.2 on March 2021 to 34.2 on March 2026 . This represents a CAGR of -3.44% over 6 years The Market Cap of Fortis Malar Hospitals Ltd changed from ₹ 103.92 crore on March 2021 to ₹ 78.13 crore on March 2026 . This represents a CAGR of -4.64% over 6 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 4774 crore on March 2021 to ₹ 5566 crore on March 2026 . This represents a CAGR of 2.59% over 6 years The revenue of Fortis Malar Hospitals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0.54 crore. This represent the decline of -100% The revenue of Thyrocare Technologies Ltd for the Sep '26 is ₹ 275.24 crore as compare to the Jun '26 revenue of ₹ 244.88 crore. This represent the growth of 12.4% The ebitda of Fortis Malar Hospitals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0.2 crore. This represent the decline of -100% The ebitda of Thyrocare Technologies Ltd for the Sep '26 is ₹ 48.74 crore as compare to the Jun '26 ebitda of ₹ 82.13 crore. This represent the decline of -40.66% The net profit of Fortis Malar Hospitals Ltd changed from ₹ -0.06 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 15.22 crore over 10 quarters. This represents a CAGR of -16.57% The Dividend Payout of Fortis Malar Hospitals Ltd changed from 168.63 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .

About Fortis Malar Hospitals Ltd

Fortis Malar Hospital Limited, formerly known as Malar Hospital Limited was established on April 12, 1989 to set up, manage and operate a multi-specialty hospital.
Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Intermediate Holding Company.
Later, the Company changed its name to 'Fortis Malar Hospital Limited' on December 21, 2010.
The Hospital building was owned by a fellow subsidiary, Fortis Health Management Limited (FHML) in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services.
With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine All the above departments are fully became operational under phase I of the project.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Fortis Malar Hospitals Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Fortis Malar Hospitals Ltd or Thyrocare Technologies Ltd?

Market cap of Fortis Malar Hospitals Ltd is 73 Cr while Market cap of Thyrocare Technologies Ltd is 7,273 Cr

What are the key factors driving the stock performance of Fortis Malar Hospitals Ltd and Thyrocare Technologies Ltd?

The stock performance of Fortis Malar Hospitals Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Malar Hospitals Ltd and Thyrocare Technologies Ltd?

As of October 30, 2026, the Fortis Malar Hospitals Ltd stock price is INR ₹39.47. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹457.0.

How do dividend payouts of Fortis Malar Hospitals Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Fortis Malar Hospitals Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.